• By ConcordGal
• Reply 3705691
• January 14, 2013 at 6:17 pm
• Report post
I began 400 mg three times a day for a total of 1200 mg of CO-1686 on December 26th. I have developed some severe back back which may, or may OT, be related to the drug. An MRI today revealed no mets, or other problems that would show up on an MRI. So, we are hoping it is a muscular issue that can be managed with a little pain meds, heat and rest. Still waiting for the genetic testing results to come back regarding the 790 mutation. My doctor thinks that will likely be positive. The good news is that, with the exception of the back pain, I have had no side effects from CO-1686. My skin, which was wrecked by Tarceva, is back to normal, as is my digestive tract. My first scan will be the 30th of January. We are all crossing our fingers.
• By ConcordGal
• Reply 3706247 • In reply to 3706030 by solozip
• January 14, 2013 at 9:38 pm
• Report post
Hi. Good to hear you are tolerating the dose well. Yes, I am at MGH for the trial after four years of treatment at Dana Farber, which I miss. They have part of my genetic work back - MET negative, FISH (sp?) indicates multiple EGFR copies. According to Dr. Sequist, that is most common with the T790M mutation. So she feels pretty sure I will be positive for the 790 mutation, but that test is still pending. I had my 15 day check up last week. Everything is looking good so far. My doctor explained that we will not need to have the 790 mutation to be in phase 2; that requirement is for new patients first starting the trial in Phase 2. Best of luck to you.
• By ConcordGal
• Reply 3707161
• January 15, 2013 at 8:58 am
• Report post
I was on Tarceva since August 2009. I was NED until Nov. 2010, when I had two spine mets. Stereotactic rad. took care of them. Then in June 2011, I had a slew of tiny tumors show up in both lungs. We moved to carbo/ alimta with Tarceva, which held everything steady until feb. 2012. Then I began a slow progression. We did a brain MRI in May 2012 in anticipation of a different trial and they found two brain lesions. Again stereotactic rad took care of them. I was not eligible for a trial at that point, but went on the list for CO-1686 at MGH. We tried Taxotere this fall, which I hated, but which workd well. Then, at last, I got into the MGH trial. It goes well, but after four years with Dr. Jackman and the Dana Farber team, I miss them. Hope everyone does well on this. After the Tarceva side effects, this drug is easy.
• By ConcordGal
• Reply 3934025
• March 26, 2013 at 8:39 am
• Report post
I am still in the CO-1686 trial (since Dec. 26, 2012) at Mass. General in Boston. At my first scan, I unfortunately had some brain mets, but the trial doesn't consider this progression. I think it is because they don't know whether this drug crosses the brain barrier. So I had whole brain radiation in February, went off the drug during the whole brain radiation and then started again. At my last scan, last week, I had no progression and, in fact, perhaps some minor shrinkage (my tumors are quite small so they are difficult to measure accurately). I continue on 1200 mg taken at 400 mg increments three times a day. I have had no side effects, and my skin and digestive tracts have returned to normal after three years of Tarceva craziness. So far, so good. We'll find out if the whole brain worked in late April.
|